Pharmacological and clinical differences between low-molecular-weight heparins: implications for prescribing practice and therapeutic interchange.
about
In vitro and in vivo characterization of a reversible synthetic heparin analog.Maternal malaria induces a procoagulant and antifibrinolytic state that is embryotoxic but responsive to anticoagulant therapy.Venous Thromboembolism (VTE) Prophylaxis for Hip and Knee Arthroplasty: Changing Trends.Uncovering the Catalytic Direction of Chondroitin AC Exolyase: FROM THE REDUCING END TOWARDS THE NON-REDUCING ENDThe design and synthesis of new synthetic low-molecular-weight heparins.Heparin-Mimicking Polymers: Synthesis and Biological Applications.De novo synthesis of a narrow size distribution low-molecular-weight heparin.Low molecular weight heparin versus unfractionated heparin in the management of cerebral venous thrombosis: A systematic review and meta-analysis.New Anticoagulants for the Prevention and Treatment of Venous Thromboembolism.Enoxaparin attenuates doxorubicin induced cardiotoxicity in rats via interfering with oxidative stress, inflammation and apoptosis.Use of Direct Oral Anticoagulants in Patients with Cancer: Practical Considerations for the Management of Patients with Nausea or Vomiting.Selection of essential medicines for the prevention and treatment of cardiovascular diseases in low and middle income countries.
P2860
Q30710756-641567ED-8EC4-4F91-853C-8E5A3927EF76Q34162714-88625032-9CEB-42DA-8F9B-711CC3A39CE6Q35140564-8E0F32AA-2D70-40C6-9F32-897E7682E34FQ36744482-58CFC940-1C14-4294-BFB5-10714A622D0CQ37004231-88F8E7CF-4A7E-481F-8711-604240787F99Q37416889-1CBEE0F9-B041-4C79-BFC5-E3EF219B5BF4Q37685686-48C6760B-520D-48FE-9491-45369AB1B02EQ37733358-3F244386-3B02-42BD-94BC-F368BC5577A6Q39213540-F5F0FAFB-5886-4ADF-8E9C-3F711E2B99BDQ47872090-F292FA25-1FEF-43A6-8961-AE1232F5143BQ52805260-0E1537A2-4DD8-41C4-A9B4-00B4E9D584DAQ55484350-BE56D141-4DD0-42AE-84D9-459A2AFF40D5
P2860
Pharmacological and clinical differences between low-molecular-weight heparins: implications for prescribing practice and therapeutic interchange.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Pharmacological and clinical d ...... e and therapeutic interchange.
@ast
Pharmacological and clinical d ...... e and therapeutic interchange.
@en
type
label
Pharmacological and clinical d ...... e and therapeutic interchange.
@ast
Pharmacological and clinical d ...... e and therapeutic interchange.
@en
prefLabel
Pharmacological and clinical d ...... e and therapeutic interchange.
@ast
Pharmacological and clinical d ...... e and therapeutic interchange.
@en
P2860
P1476
Pharmacological and clinical d ...... ce and therapeutic interchange
@en
P2093
Geno J Merli
James B Groce
P2860
P304
P577
2010-02-01T00:00:00Z